Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene.

Angiotensins Humans Neurons Parkinson Disease / genetics Receptors, Angiotensin Substantia Nigra

Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
08 2022
Historique:
revised: 01 06 2022
received: 25 05 2022
accepted: 06 06 2022
pubmed: 30 6 2022
medline: 20 8 2022
entrez: 29 6 2022
Statut: ppublish

Résumé

© 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Identifiants

DOI: 10.1002/mds.29137 PMID: 35766438 PMC: PMC9544027
pubmed: 35766438
doi: 10.1002/mds.29137
pmc: PMC9544027
doi:

Substances chimiques

Angiotensins 0
Receptors, Angiotensin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1611

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Références

Nat Neurosci. 2022 May;25(5):588-595
pubmed: 35513515
Elife. 2021 Sep 22;10:
pubmed: 34550070
Prog Neurobiol. 2021 Apr;199:101919
pubmed: 33039415
Neurotherapeutics. 2018 Oct;15(4):1063-1081
pubmed: 29987762
Front Pharmacol. 2022 Mar 03;13:837890
pubmed: 35308220

Auteurs

Jose L Labandeira-Garcia (JL)

Laboratory of Cellular and Molecular Neurobiology of Parkinson's Disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
ORCID: 0000-0002-8243-9791

Juan A Parga (JA)

Laboratory of Cellular and Molecular Neurobiology of Parkinson's Disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.
ORCID: 0000-0003-2072-5642

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Autacoïdes › Angiotensines › Nigral Neurons Degenerating in Parkinson's...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Nigral Neurons Degenerating in Parkinson's...
questionsmedicales.fr › Cellules › Neurones › Nigral Neurons Degenerating in Parkinson's...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Nigral Neurons Degenerating in Parkinson's...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteurs aux angiotensines › Nigral Neurons Degenerating in Parkinson's...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Tronc cérébral › Mésencéphale › Pédoncule cérébral › Substantia nigra › Nigral Neurons Degenerating in Parkinson's...